🤔 Does #vaping increase your risk of developing #lungcancer ?

While research in this area is still relatively new, Lung Cancers Today delved into the topic with returning KOL Dr. Marisa Bittoni.

📺 Watch Now: buff.ly/3JLiv7Q

he will be in Chicago at the First annual #HemOnc Pulse LIVE #HOPLive24 amongst faculty tackling 'Unanswered Questions' in Heme Cancers. Aaron Goodman - “Papa Heme” will be a panelist on the Bispecifics & Myeloma sessions & expect fireworks - he is also MOC-ready. Blood Cancers Today
Stay tuned

We asked over 300 healthcare leaders about their digital strategies. See how your organization compares and check out Huron’s latest research for more.

#ACC24 provided opportunities for in-person collaboration and dissemination of cutting-edge research for the ACPC community.

Read an expert analysis on ACPC perspective on ACC.24: bit.ly/3wkIwYg #ACCACPC

🔴 Spectrum of Ischemic Heart Disease Throughout a Woman’s Life Cycle
#openaccess #2024Review

✅SCAD is an important cause of acute MI in women under 50, particularly in the context of pregnancy.

✅journal.houstonmethodist.org/articles/10.14…
#CardioTwitter
#medx #MedEd #CardioEd #Cardiology

📰 Patient-derived organoids have shown promise in modeling #lungcancer therapy response. #lungcancer stoday

buff.ly/4aYgqRF 👈 Read More❗

📰 Mithu Maheswaranathan, MD details the increasing interest in the use of #musculoskeletal ultrasound in #pediatricrheumatology . #rheumatology #pediatrics #rheumnews

Read More❕ ❗: buff.ly/3UHISBT

📰 chadi nabhan MD, MBA, FACP is joined by Manmeet Ahluwalia, MD, MBA, FASCO, Miami Cancer Institute Research, to delve into the latest breakthroughs in primary #braincancers . #braintumors

👂 Listen Now❗: buff.ly/3xSp7OQ

🗞️ Cancer organoid-based drug sensitivity tests have recently been investigated to predict responses to #anticancer drugs. #lungcancer #lungcancer stoday

📰 Read More: buff.ly/49ZdQJR

📖 A study that assessed the impact of miR-29a and miR-143 on gene expression in #lungcancer . #lungcancer stoday

👀 Read More❕: buff.ly/49Xf0FP

📰 A study that examined whether the combination of 🤖 #AI and knowledge can identify more patients with lung and ovarian cancers. #lungcancer #ovariancancer #lungcancer stoday

👀 Read More❗: buff.ly/4dim1E6

I've been working for MashupMD for the last year covering developments in nephrology and it has been delightful. It feels like a return to blogging for me. Here's my latest:

mashupmd.com/expert-collect…

Join myself & Dr. Grobbee Diederick E. Grobbee as we discuss the approach to management & diagnosis of #MINOCA with European Society of Cardiology #ESCTV INOCA INTERNATIONAL
Thank you to ESC for covering this important topic!

esc365.escardio.org/event/1149

🔴Practical approach for atrial cardiomyopathy characterization in patients with atrial fibrillation #openaccess #2024Review

✅revespcardiol.org//en-practical-…
#CardioEd #Cardiology #FOAMed #cardiotwiteros #MedEd #medtwitter what #medtwitter #CardioEd #CardioTwitter #cardiology #medx

Still have #CowboyCarter on repeat? Us too! Because BEYONCÉ’s music could help you save a life with Hands-Only CPR.

Remember, if you see a teen or adult collapse, call 911, then push hard & fast in the center of the chest to the beat of FLAMENCO. #NationofLifesavers #QueenBey

“Instead of thinking of breast cancer as a death sentence, it should now be thought of as another illness — and one that can be met with favorable outcomes,” says Dr. Gabriel Hortobagyi of treatment advances in #BreastCancer . brnw.ch/21wJiFf Women's Health #EndCancer

Tomorrow is the last day to save on registration for #ACCAthleticHeart !

Register to join us June 6 – 8 at Heart House or virtually to learn about fundamental diagnostic & management strategies & treatment options from #SportsCardio experts. bit.ly/3V8WpmD

#JACCIMG study revealed that HRP features on CTA correspond to features of plaque vulnerability on OCT. Plaques w/ multiple HRP features exhibit higher prevalence of vulnerable OCT features. Patients w/ HRP had an increased incidence of future CV events. bit.ly/3UCtJBF

A randomized trial of an AI based system to warn MDs of patients at high risk reduced the risk of cardiac death (0.2% in the intervention arm versus 2.4% in the control arm, HR = 0.07, 95% CI = 0.01–0.56).

nature.com/articles/s4159…

Positive results from Destiny B06: T-DXd demonstrated PFS improvement over chemotherapy in the primary and overall trial population (incl HER2-low and ultralow). #bcsm @oncoalert astrazeneca.com/media-centre/p…